Christopher DiSimone
Impact in
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 5
- Cancer Immunotherapy and Biomarkers 5
-
- Endometrial and Cervical Cancer Treatments 5
- Co-authors
- Daniel E. Stepan (6 shared papers)Matthew H. Taylor (8 shared papers)Allen Lee Cohn (7 shared papers)Corina E. Dutcus (7 shared papers)Emmett V. Schmidt (7 shared papers)Mark Messing (4 shared papers)Ana Oaknin (3 shared papers)Carol Aghajanian (4 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Annals of Oncology (3 papers)Gynecologic Oncology (1 paper)
- Partner nations
- United StatesSpainCzechia
In The Last Decade
Christopher DiSimone
10 papers receiving 487 citations
Christopher DiSimone's Hit Papers
Peers
Comparison fields: 5 of 45
- Obstetrics and Gynecology 176
- Reproductive Medicine 133
- Oncology 271
- Cancer Research 85
- Pulmonary and Respiratory Medicine 148
Countries citing papers authored by Christopher DiSimone
This map shows the geographic impact of Christopher DiSimone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher DiSimone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher DiSimone more than expected).
Fields of papers citing papers by Christopher DiSimone
This network shows the impact of papers produced by Christopher DiSimone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher DiSimone. The network helps show where Christopher DiSimone may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher DiSimone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer Hit paper breakdown → | 2020 | 359 |
| 2 | 2021 | 90 | |
| 3 | 2019 | 9 | |
| 4 | 2019 | 9 | |
| 5 | 2020 | 7 | |
| 6 | 2019 | 6 | |
| 7 | 2013 | 4 | |
| 8 | 2019 | 3 | |
| 9 | 2020 | 2 | |
| 10 | 2021 | 1 |
About Christopher DiSimone
Christopher DiSimone is a scholar working on Oncology, Obstetrics and Gynecology, Molecular Biology, Pulmonary and Respiratory Medicine and Reproductive Medicine, having authored 10 papers that have together received 490 indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Ovarian cancer diagnosis and treatment (4 papers), Endometriosis Research and Treatment (3 papers), Renal cell carcinoma treatment (3 papers), Angiogenesis and VEGF in Cancer (2 papers), Urinary and Genital Oncology Studies (1 paper) and Prostate Cancer Treatment and Research (1 paper). The work is most often cited by research in Obstetrics and Gynecology (176 citations), Reproductive Medicine (133 citations), Oncology (271 citations), Cancer Research (85 citations) and Pulmonary and Respiratory Medicine (148 citations). Christopher DiSimone has collaborated with scholars based in United States, Spain and Czechia. Frequent co-authors include Daniel E. Stepan, Matthew H. Taylor, Allen Lee Cohn, Corina E. Dutcus, Emmett V. Schmidt, Mark Messing, Ana Oaknin, Carol Aghajanian, Vicky Makker and Marcia S. Brose. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.